The European Commission Friday cleared pharmaceuticals company Merck & Co. (MRK) to buy Schering-Plough Corp. (SGP).

Merck is paying $41.1 billion in cash and stock for Schering.

To avoid antitrust problems, Merck has sold its 50% stake in animal-health company Merial Limited to Sanofi-Aventis SA (SNY), its partner in the joint venture.

-By Adam Cohen, Dow Jones Newswires; +322 741 1486; adam.cohen@dowjones.com
Schering Plough (NYSE:SGP)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024 Plus de graphiques de la Bourse Schering Plough
Schering Plough (NYSE:SGP)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024 Plus de graphiques de la Bourse Schering Plough